Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP
Clinical trial NCT03196947 · TERMINATED
Trial details
- NCT number
- NCT03196947
- Sponsor
- Allarity Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2020-01-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.